102 related articles for article (PubMed ID: 10050725)
21. Flow cytometric monocyte phagocytic assay for predicting platelet transfusion outcome.
Lim J; Kim Y; Han K; Kim M; Lee KY; Kim WI; Shim SI; Kim BK; Kang CS
Transfusion; 2002 Mar; 42(3):309-16. PubMed ID: 11961235
[TBL] [Abstract][Full Text] [Related]
22. Detection and identification of platelet-associated alloantibodies by a solid-phase modified antigen capture enzyme-linked immunosorbent assay method and its correlation to platelet refractoriness in multiplatelet concentrate-transfused patients.
Jain N; Sarkar S; Philip J
Immunohematology; 2014; 30(3):123-5. PubMed ID: 25695438
[TBL] [Abstract][Full Text] [Related]
23. HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets.
O'Rafferty C; Rooney G; Hagan R; Woolfson M; O'Donghaile D; Fitzgerald J
Transfus Med; 2017 Oct; 27 Suppl 5():369-374. PubMed ID: 28393455
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies.
Gerber B; Alberio L; Rochat S; Stenner F; Manz MG; Buser A; Schanz U; Stussi G
Transfusion; 2016 Oct; 56(10):2426-2437. PubMed ID: 27339466
[TBL] [Abstract][Full Text] [Related]
25. Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant.
Rosenbaum ER; Pandey S; Harville TO; Drobena GA; Cottler-Fox M
Ann Clin Lab Sci; 2016 Dec; 46(6):662-665. PubMed ID: 27993881
[TBL] [Abstract][Full Text] [Related]
26. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
Levy L; Woodfield DG
N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
[TBL] [Abstract][Full Text] [Related]
27. Ultraviolet light-based pathogen inactivation and alloimmunization after platelet transfusion: results from a randomized trial.
Norris PJ; Kaidarova Z; Maiorana E; Milani S; Lebedeva M; Busch MP; Custer B; Rebulla P
Transfusion; 2018 May; 58(5):1210-1217. PubMed ID: 29473173
[TBL] [Abstract][Full Text] [Related]
28. A Novel Flow Cytometric Method for the Simultaneous Detection of Antibodies Against Platelet, Lymphocyte, And Neutrophil.
Suh MC; Suh JS; Won DI
Cytometry B Clin Cytom; 2018 Mar; 94(2):281-290. PubMed ID: 27631163
[TBL] [Abstract][Full Text] [Related]
29. Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients.
Godeau B; Fromont P; Seror T; Duedari N; Bierling P
Br J Haematol; 1992 Jul; 81(3):395-400. PubMed ID: 1390213
[TBL] [Abstract][Full Text] [Related]
30. An alloimmunized, thrombocytopenic patient successfully transfused with acid-treated, random-donor platelets.
Shanwell A; Sallander S; Olsson I; Gulliksson H; Pedajas I; Lerner R
Br J Haematol; 1991 Nov; 79(3):462-5. PubMed ID: 1751374
[TBL] [Abstract][Full Text] [Related]
31. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.
Claas FH; Smeenk RJ; Schmidt R; van Steenbrugge GJ; Eernisse JG
Exp Hematol; 1981 Jan; 9(1):84-9. PubMed ID: 7238645
[TBL] [Abstract][Full Text] [Related]
32. [Application of microcolumn gel immunoassay in screening the platelet antibody].
Xu DY; Dong GF; Zhang Z; Peng MX; Du Y; Chen CS; Tang XX; Fu JY; Gao JL; Bai J; Ma YL; Qian BY; Ma JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):888-91. PubMed ID: 17708827
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates.
McFarland JG; Anderson AJ; Slichter SJ
Br J Haematol; 1989 Nov; 73(3):380-6. PubMed ID: 2605125
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of anti-platelet antibodies using flow cytometry].
Tsubaki K
Rinsho Byori; 1993 Sep; 41(9):998-1006. PubMed ID: 8254978
[TBL] [Abstract][Full Text] [Related]
35. Effects of storage time on quantitative and qualitative platelet function after transfusion.
Rosenfeld BA; Herfel B; Faraday N; Fuller A; Braine H
Anesthesiology; 1995 Dec; 83(6):1167-72. PubMed ID: 8533908
[TBL] [Abstract][Full Text] [Related]
36. The alloimmunized patient: effective transfusion support and newer experimental approaches.
Pamphilon DH
Blood Coagul Fibrinolysis; 1992 Oct; 3(5):651-4. PubMed ID: 1450334
[TBL] [Abstract][Full Text] [Related]
37. Platelet transfusions.
Stroncek DF; Rebulla P
Lancet; 2007 Aug; 370(9585):427-38. PubMed ID: 17679020
[TBL] [Abstract][Full Text] [Related]
38. [Managing of platelet transfusion refractoriness of haematological malignancies. Experience IPC-EFSAM].
Dettori I; Ladaique P
Transfus Clin Biol; 2014 Nov; 21(4-5):207-9. PubMed ID: 25267204
[TBL] [Abstract][Full Text] [Related]
39. Transient platelet and HLA antibody formation in multitransfused patients with malignancy.
McGrath K; Wolf M; Bishop J; Veale M; Ayberk H; Szer J; Cooper I; Whiteside M
Br J Haematol; 1988 Mar; 68(3):345-50. PubMed ID: 3355793
[TBL] [Abstract][Full Text] [Related]
40. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
